FrancophonIA/ELRC3.0 huggingface dataset:
English: This medicinal product must not be mixed with calcium or other divalent cation-containing infusion solutions such as lactated Ringer's solution, and should be administered as a single intravenous solution in a separate infusion line.
Croatian: Ovaj se lijek ne smije miješati s kalcijem ili drugim otopinama za infuziju koje sadrže dvovalentne katione, kao što je Ringerova otopina s laktatom, te ga treba primijeniti kao zasebnu intravensku otopinu putem zasebne infuzijske linije.
English: Zoledronic Acid Teva concentrate must not be mixed with calcium or other divalent cation-containing infusion solutions such as lactated Ringer's solution, and should be administered as a single intravenous solution in a separate infusion line.
Croatian: Zoledronatna kiselina Teva ne smije se miješati s kalcijem ili drugim otopinama za infuziju koje sadrže dvovalentne katione, kao što je Ringerova otopina s laktatom, i treba se primijeniti kao jednokratna intravenska otopina kroz posebnu infuzijsku liniju.
English: Osteonecrosis of the jaw (ONJ) has been reported uncommonly in clinical trials and in the post-marketing setting in patients receiving Zoledronic Acid Teva.
Croatian: Osteonekroza čeljusti zabilježena je manje često u kliničkim ispitivanjima i nakon stavljanja lijeka u promet u bolesnika koji su se liječili Zoledronatnom kiselinom Teva.
English: Blurred vision, scleritis and orbital inflammation
Croatian: konjunktivitis zamagljen vid, skleritis i upala orbite uveitis episkleritis
English: Only clear solution free from particles and discolouration should be used.
Croatian: Smije se primijeniti samo bistra otopina bez vidljivih čestica i promjene boje.
English: There have been very rare cases of drowsiness and sleepiness with the use of zoledronic acid.
Croatian: U vrlo su rijetkim slučajevima uz primjenu zoledronatne kiseline nastupile omamljenost i pospanost.
English: Instructions for preparing reduced doses of Zoledronic Acid Teva Withdraw an appropriate volume of the concentrate needed, as follows: - 4.4 ml for 3.5 mg dose - 4.1 ml for 3.3 mg dose
Croatian: Izvucite odgovarajući volumen potrebnog koncentrata na sljedeći način: - 4,4 ml za dozu od 3,5 mg
English: How to store Zoledronic Acid Teva
Croatian: Kako primjenjivati Zoledronatnu kiselinu Teva
English: Tell your doctor immediately if you experience symptoms such as new onset or worsening of aches, pain or stiffness while being treated with Zoledronic Acid Teva or after stopping treatment.
Croatian: Odmah obavijestite svog liječnika ako za vrijeme liječenja Zoledronatnom kiselinom Teva ili nakon prestanka liječenja dobijete simptome kao što su novonastali ili pogoršani bolovi ili ukočenost.
English: Discontinuation of bisphosphonate therapy in patients suspected to have an atypical femur fracture should be considered pending evaluation of the patient, based on an individual benefit risk assessment.
Croatian: Do nalaza pregleda bolesnika u kojih postoji sumnja na atipični prijelom bedrene kosti, potrebno je razmotriti i prekid terapije bisfosfonatima na temelju procjene omjera koristi i rizika liječenja u pojedinog bolesnika.
English: The following properties have been demonstrated in preclinical studies: - In vivo: Inhibition of osteoclastic bone resorption, which alters the bone marrow microenvironment, making it less conducive to tumour cell growth, anti-angiogenic activity and anti-pain activity.
Croatian: − in vivo: inhibicija osteoklastične resorpcije kosti, koja mijenja mikrookoliš koštane srži i čini je manje pogodnom za rast tumorskih stanica, antiangiogeno djelovanje i analgetsko djelovanje.
English: Figure 1: Mean changes from baseline in BPI scores.
Croatian: Slika 1: Srednja vrijednost promjene rezultata na ljestvici boli (BPI) od početne vrijednosti.
English: Danmark Teva Denmark A/S Tlf: +45 44 98 55 11
Croatian: Tlf: +45 44 98 55 11
English: Blood creatinine and blood urea increased, hypocalcaemia
Croatian: hipofosfatemija povišeni kreatinin i urea u krvi, hipokalcemija hipomagnezemija, hipokalemija hiperkalemija, hipernatremija
English: Very rare (may affect up to 1 in 10,000 people):
Croatian: Vrlo često (mogu se javiti u više od 1 na 10 osoba):
English: To avoid potential incompatibilities, Zoledronic Acid Teva concentrate is to be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or 5% w/v glucose solution.
Croatian: Kako bi se izbjegle potencijalne inkompatibilnosti, koncentrat Zoledronatne kiseline Teva mora se razrijediti otopinom za injekciju natrijeva klorida 9 mg/ml (0,9%) ili 5% m/V otopinom glukoze.
English: 6.6 Special precautions for disposal and other handling Prior to administration, 5 ml concentrate from one vial or the volume of the concentrate withdrawn as required must be further diluted with 100 ml of calcium-free infusion solution (sodium chloride 9 mg/ml (0.9%) solution for injection or 5% w/v glucose solution).
Croatian: Prije primjene, 5 ml koncentrata iz jedne bočice ili potreban volumen koncentrata izvučen iz jedne bočice mora se dodatno razrijediti sa 100 ml otopine za infuziju koja ne sadrži kalcij (otopina natrijevog klorida za injekciju od 9 mg/ml (0,9%) ili 5%-tna m/V otopina glukoze).
English: How Zoledronic Acid Teva is given
Croatian: Koliko se Zoledronatne kiseline Teva daje
English: You must not be given Zoledronic Acid Teva if you are breast-feeding.
Croatian: Ne smijete dobivati Zoledronatnu kiselinu Teva ako dojite.
English: One vial contains 4 mg zoledronic acid, (as monohydrate).
Croatian: Jedna bočica sadrži 4 mg zoledronatne kiseline (u obliku hidrata).
English: Suomi/Finland rationpharm Oy Puh/Tel: +358 20 180 5900
Croatian: Puh/Tel: +358 20 180 5900
English: To avoid potential incompatibilities, the infusion solution used for dilution must be either sodium chloride 9 mg/ml (0.9%) solution for injection or 5% w/v glucose solution.
Croatian: Da biste izbjegli moguće inkompatibilnosti, otopina za infuziju koja se koristi za razrjeđenje mora biti otopina za injekciju natrijevog klorida od 0,9 mg/ml (0,9%) ili 5%-tna m/V
English: Irregular heart beat (cardiac arrhythmia), seizures, spasm and twitching (tetany) have been reported as secondary to severe hypocalcaemia.
Croatian: Nepravilni otkucaji srca (srčane aritmije), napadaji, grčevi i trzanje mišića (tetanija) zabilježeni su uz jaku hipokalcemiju.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One vial with 5 ml concentrate contains 4 mg zoledronic acid (as monohydrate).
Croatian: Jedna bočica s 5 ml koncentrata sadrži 4 mg zoledronatne kiseline (u obliku hidrata).
English: Zoledronic Acid Teva recommended dose* 4.0 mg zoledronic acid 3.5 mg* zoledronic acid 3.3 mg* zoledronic acid 3.0 mg* zoledronic acid *Doses have been calculated assuming target AUC of 0.66 (mg•hr/l) (CLcr = 75 ml/min).
Croatian: 4,0 mg zoledronatne kiseline 3,5 mg* zoledronatne kiseline 3,3 mg* zoledronatne kiseline 3,0 mg* zoledronatne kiseline
English: Zoledronic Acid Teva 4 mg/5 ml concentrate for solution for infusion zoledronic acid
Croatian: Zoledronatna kiselina Teva 4 mg/5 ml koncentrat za otopinu za infuziju zoledronatna kiselina
English: Ask your doctor for advice before taking any medicine while you are pregnant or breast-feeding.
Croatian: Ako ste trudni ili dojite, obratite se svom liječniku za savjet prije nego što uzmete bilo koji lijek.
English: The hydration status of patients must be assessed prior to and following administration of Zoledronic Acid Teva to ensure that they are adequately hydrated.
Croatian: Prije i poslije primjene Zoledronatne kiseline Teva mora se provjeriti status hidracije bolesnika kako bi se osiguralo da su primjereno hidrirani.
English: Standard hypercalcaemia-related metabolic parameters, such as serum levels of calcium, phosphate and magnesium, should be carefully monitored after initiating Zoledronic Acid Teva therapy.
Croatian: Nakon početka terapije Zoledronatnom kiselinom Teva potrebno je pažljivo pratiti standardne metaboličke parametre hiperkalcemije, kao što su razine kalcija, fosfata i magnezija u serumu.
English: Zoledronic acid was teratogenic in the rat at subcutaneous doses ≥ 0.2 mg/kg.
Croatian: Zoledronatna kiselina primijenjena supkutano u dozama ≥ 0,2 mg/kg u štakora pokazala je teratogeno djelovanje.
English: - Low level of magnesium and potassium in the blood.
Croatian: - Niska razina fosfata u krvi.
English: Rare (may affect up to 1 in 1,000 people): - Slow heart beat.
Croatian: Rijetko (mogu se javiti u do 1 na 1000 osoba): - Kao posljedica niskih razina kalcija: nepravilni otkucaji srca (srčana artimija, uslijed hipokalcemije).
English: 5.1 Pharmacodynamic properties
Croatian: 5. FARMAKOLOŠKA SVOJSTVA 5.1 Farmakodinamička svojstva
English: Hypophosphataemia
Croatian: hipokalcemija hipofosfatemija
English: In the clinical studies, patients with serum creatinine > 400 μmol/l or > 4.5 mg/dl were excluded.
Croatian: Bolesnici s vrijednostima kreatinina u serumu većima od 400 μmol/l ili 4,5 mg/dl bili su isključeni iz kliničkih ispitivanja.
English: 4 x 5 ml vials
Croatian: 4 x 5 ml bočice 10 x 5 ml bočica
English: Fever, flu-like syndrome (including fatigue, rigors, malaise and flushing)
Croatian: vrućica, sindrom nalik gripi (uključujući umor,
English: 10 x 5 ml vials
Croatian: 1 x 5 ml bočica
English: The refrigerated solution should then be equilibrated to room temperature before administration.
Croatian: Prije primjene rashlađenu otopinu treba pustiti da dosegne sobnu temperaturu.
English: This medicinal product contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially “sodium-free”.
Croatian: Važne informacije o nekim sastojcima Zoledronatne kiseline Teva Ovaj lijek sadrži manje od 1 mmol (23 mg) natrija po bočici, tj. zanemarive količine natrija.
English: Excipients
Croatian: Pamidronat
English: In clinical trials with zoledronic acid, patients with serum creatinine > 265 μmol/l or > 3.0 mg/dl were excluded.
Croatian: Bolesnici s vrijednošću kreatinina u serumu većom od 265 μmol/l ili 3,0 mg/dl bili su isključeni iz kliničkih ispitivanja sa zoledronatnom kiselinom.
English: Zoledronic Acid Teva treatment should be resumed at the same dose as that given prior to treatment interruption.
Croatian: Teva smije se nastaviti istom dozom koja se davala prije prekida liječenja.
English: Furthermore, there is evidence of an association between hypocalcaemia and secondary neurological events reported in these cases including;
Croatian: Nadalje, postoje dokazi o povezanosti hipokalcemije i sekundardnih neuroloških nuspojava prijavljenih u tim slučajevima, uključujući konvulzije, hipoesteziju i tetaniju (vidjeti dio 4.4) Prijavljivanje sumnji na nuspojavu
English: For instructions of the dilution of the medicinal product before administration, see section 6.6.
Croatian: - 3,8 ml za dozu od 3,0 mg Za uputu o otapanju lijeka prije primjene, vidjeti dio 6.6.
English: Teva Pharmaceuticals Ireland Tel: +353 51 321 740
Croatian: Tel: +353 51 321 740
English: Important information about some of the ingredients in Zoledronic Acid Teva
Croatian: Sadržaj pakiranja i druge informacije Što Zoledronatna kiselina Teva sadrži
English: Very rare:
Croatian: Vrlo rijetko.
English: Österreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1 97007-0
Croatian: Österreich ratiopharm Arzneimittel Vertriebs-GmbH
English: Zoledronic acid does not inhibit human P450 enzymes in vitro, shows no biotransformation and in animal studies < 3% of the administered dose was recovered in the faeces, suggesting no relevant role of liver function in the pharmacokinetics of zoledronic acid.
Croatian: < 3% primijenjene doze otkrilo se u fecesu, što pokazuje da funkcija jetre nema važnu ulogu u farmakokinetici zoledronatne kiseline.
English: NAME OF THE MEDICINAL PRODUCT Zoledronic Acid Teva 4 mg/5 ml concentrate for solution for infusion
Croatian: Zoledronatna kiselina Teva 4 mg/5 ml koncentrat za otopinu za infuziju
English: PLIVA Croatia Ltd
Croatian: Pliva Hrvatska d.o.o
English: Dizziness, paraesthesia, dysgeusia, hypoaesthesia, hyperaesthesia, tremor, somnolence
Croatian: glavobolja omaglica, parestezija, disgeuzija, hipoestezija,
English: If you get any side effects, talk to your doctor pharmacist or nurse.
Croatian: Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika, ljekarnika ili medicinsku sestru.
English: UAB "Sicor Biotech" Tel: +370 5 266 02 03
Croatian: Tel: +370 5 266 02 03
English: Nederland Teva Nederland B.V. Tel: +31 800 0228400
Croatian: Tel: +31 800 0228400
English: Batch
Croatian: tahikardija
English: Pamidronate 90 mg (N=99) *p-values compared to pamidronate.
Croatian: *p-vrijednosti u usporedbi s pamidronatom.
English: Prevention of skeletal related events in patients with advanced malignancies involving bone Adults and elderly people
Croatian: Sprječavanje koštanih događaja u bolesnika s uznapredovalom zloćudnom bolešću koja je zahvatila kosti
English: NA Not Applicable
Croatian: NP Nije primjenjivo.
English: METHOD OF ADMINISTRATION Dilute before use.
Croatian: Razrijediti prije primjene.
English: The onset time is ≤ 3 days post-zoledronic acid infusion, and the reaction is also referred to using the terms “flu-like” or “post-dose” symptoms.
Croatian: Ta se reakcija još zove simptomi “nalik gripi” ili simptomi “nakon doziranja”.
English: METHOD AND ROUTE(S) OF ADMINISTRATION For single use only.
Croatian: NAČIN I PUT(EVI) PRIMJENE LIJEKA
English: Renal impairment
Croatian: Razrijeđena otopina
English: UAB "Sicor Biotech" filiāle Latvijā Tel: +371 67 323 666
Croatian: Latvija UAB "Sicor Biotech" filiāle Latvijā
English: - Chest pain.
Croatian: otopina glukoze.
English: In a second study including solid tumours other than breast or prostate cancer, zoledronic acid 4 mg significantly reduced the proportion of patients with an SRE, delayed the median time to first SRE by > 2 months, and reduced the skeletal morbidity rate.
Croatian: zoledronatna kiselina u dozi od 4 mg značajno je smanjila udio bolesnika s koštanim događajima, produljila medijan vremena do prvog koštanog događaja za više od 2 mjeseca i smanjila stopu koštanog pobola.
English: You should not be given Zoledronic Acid Teva: - if you are breast-feeding.
Croatian: Ne smijete primiti Zoledronatnu kiselinu Teva:
English: Sodium citrate Water for injections
Croatian: 6. FARMACEUTSKI PODACI 6.1 Popis pomoćnih tvari manitol natrijev citrat voda za injekcije
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Zoledronic Acid Teva 4 mg/5 ml sterile concentrate zoledronic acid
Croatian: Uputa o lijeku: Informacije za korisnika Zoledronatna kiselina Teva 4 mg/5 ml koncentrat za otopinu za infuziju zoledronatna kiselina
English: Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone.
Croatian: - Rijetko može nastati neuobičajen prijelom bedrene kosti osobito u bolesnika koji se dugotrajno liječe zbog osteoporoze; osjetite li bol, slabost ili nelagodu u bedru, kuku ili preponama, odmah se javite liječniku, jer to mogu biti rani znakovi mogućeg prijeloma bedrene kosti.
English: Gastrointestinal disorders Very common:
Croatian: Poremećaji probavnog sustava Često:
English: During post-marketing experience the following reactions have been reported (frequency rare): Atypical subtrochanteric and diaphyseal femoral fractures (bisphopsphonate class adverse reaction).
Croatian: atipični suptrohanterični prijelomi i prijelomi dijafize bedrene kosti (nuspojava razreda bisfosfonata).
English: United Kingdom Teva UK Limited Tel: +44 1977 628 500 This leaflet was last revised in {MM/YYYY} Other sources of information Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Croatian: Detaljnije informacije o ovom lijeku dostupne su na internetskoj stranici Europske agencije za lijekove: http://www.ema.europa.eu.
English: Episcleritis
Croatian: OBLIK
English: UAB "Sicor Biotech" Eesti filiaal Tel: +372 661 0801
Croatian: UAB "Sicor Biotech" Eesti filiaal
English: Contents of the pack and other information
Croatian: OBLIK I SADRŽAJ
English: Serum calcium should be measured and hypocalcaemia must be corrected before initiating Zoledronic Acid Teva therapy.
Croatian: Prije uvođenja terapije Zoledronatnom kiselinom Teva potrebno je odrediti razinu kalcija u serumu i korigirati hipokalcemiju.
English: 4 July 2015
Croatian: 4. srpnja 2015.
English: November 2017
Croatian: Studeni 2017.
English: Within 30 days following EC decision
Croatian: U roku od 30 dana nakon usvajanja odluke
English: Final study report by:
Croatian: Konačno izvješće ispitivanja dostaviti do:
English: This will highlight the risks and warnings of genotoxicity reactions.
Croatian: U ovom materijalu moraju biti istaknuti rizici i upozorenja o genotoksičnim reakcijama.
English: Thiocolchicoside takes part in the PSUR synchronisation project of the Heads of Medicine Agencies.
Croatian: Tiokolhikozid uključen je u Projekt sinkronizacije PSUR-a voditelja agencija za lijekove.
English: National competent authorities of Member State(s) coordinated by reference Member State(s) if applicable, shall ensure that the following conditions are fulfilled by the MAH(s):
Croatian: Nadležna nacionalna tijela država članica koje koordiniraju referentne države članice, ako se primjenjuje, trebaju osigurati da nositelji odobrenja ispune sljedeće uvjete:
English: The MAH(s) should submit the next PSUR by:
Croatian: Nositelji odobrenja trebaju dostaviti sljedeći PSUR do:
English: The MAHs should submit a risk management plan (including outline of DUS and educational materials, see also below) in EU format.
Croatian: Nositelji odobrenja trebaju dostaviti plan upravljanja rizicima (uključujući i nacrt DUS-a te edukacijske materijale, vidjeti također niže u tekstu) u EU formatu.
English: The MAH(s) should provide within the risk management plan submission, a protocol for the drug utilisation study to characterise prescribing practices for the medicinal products during typical clinical use in representative groups of prescribers and to assess main reasons for prescription.
Croatian: Nositelji odobrenja trebaju dostaviti u sklopu podnošenja plana upravljanja rizicima, protokol o ispitivanju primjene lika kako bi se okarakterizirala praksa propisivanja lijekova tijekom tipične kliničke primjene unutar reprezentativnih grupa propisivača i ocijenili glavni razlozi za propisivanje.
English: The MAHs should provide within the risk management plan educational material for prescribers and patients.
Croatian: Nositelji odobrenja trebaju dostaviti u sklopu podnošenja plana upravljanja rizicima edukacijski materijal za propisivače i bolesnike.
English: The MAHs should circulate the agreed DHPC in coordination with the NCAs according to the action plan agreed by CHMP.
Croatian: Nositelji odobrenja trebaju poslati usuglašena pisma liječnicima u dogovoru s nacionalnim nadležnim tijelima u skladu s planom djelovanja usuglašenim sa CHMP-om.
English: --1 Strains of inactivated swine influenza A virus: Bakum/IDT1769/2003 (H3N2): ≥ 10.53 log2 GMNU* Haselünne/IDT2617/2003 (H1N1): ≥ 10.22 log2 GMNU* Bakum/1832/2000 (H1N2): ≥ 12.34 log2 GMNU* * GMNU - Geometric mean of neutralizing units induced in Guinea pigs after twice immunisation with 0.5 ml of this vaccine
Croatian: Haselünne/IDT2617/2003 (H1N1) ≥ 10,22 log2 GMNU Bakum/1832/2000 (H1N2)
English: 8 vials Zero days
Croatian: 8 bočice
English: Repeat at least three times.
Croatian: Ponovite ovaj postupak najmanje tri puta.
English: After first opening: 1 month.
Croatian: Nakon prvoga otvaranja: 1 mjesec
English: • Tell your doctor:
Croatian: • Obavijestite svog liječnika:
English: ** based on historical comparison
Croatian: ** na temelju povijesne usporedbe
English: Study 020 24 weeks
Croatian: Ispitivanje 020 24 tjedna
English: For bottles: 3 years
Croatian: Za boce: 3 godine
English: Date of latest renewal: 23 April 2014.
Croatian: Datum posljednje obnove: 23. travnja 2014.
English: • Stocrin must be taken every day.
Croatian: • Stocrin morate uzimati svaki dan.
English: • Once you start taking Stocrin, look out for:
Croatian: • Nakon što počnete uzimati Stocrin, obratite pozornost na:
English: Stocrin with food and drink
Croatian: Stocrin s hranom i pićem
English: , completed suicide
Croatian: , počinjeno samoubojstvo
English: Date of first authorisation: 28 May 1999.
Croatian: Datum prvog odobrenja: 28. svibnja 1999.
English: Control regimen (n=635)
Croatian: kontrolni protokol (n=635)
English: This combination should be used with caution.
Croatian: Ova kombinacija mora se primjenjivati uz oprez.
English: Children and adolescents (3 to 17 years)
Croatian: Djeca i adolescenti (3 do 17 godina)
English: Do not take Stocrin:
Croatian: Nemojte uzimati Stocrin:
English: • if any member of your family (parents, grandparents, brothers or sisters) has died suddenly due to a heart problem or was born with heart problems.
Croatian: • ako je netko od članova Vaše obitelji (roditelji, bake i djedovi, braća ili sestre) iznenada umro zbog tegoba sa srcem ili su rođeni s bolešću srca.
English: C.I., confidence interval.
Croatian: C.I., interval pouzdanosti.
English: If parts of the syringe are not clean, repeat the cleaning instructions.
Croatian: Ako neki dijelovi štrcaljke nisu čisti, ponovite postupak čišćenja prema uputama.
English: Do not put the syringe in a dishwasher.
Croatian: Ne stavljajte štrcaljku u perilicu posuđa.
English: 95 % confidence intervals.
Croatian: 95% interval pouzdanosti.
English: • You must remain under the care of your doctor while taking Stocrin.
Croatian: • Morate ostati pod nadzorom svog liječnika dok uzimate Stocrin.
English: You must not take Stocrin with certain medicines.
Croatian: Ne smijete uzimati Stocrin s određenim lijekovima.
English: • It is recommended that the tablet be swallowed whole with water.
Croatian: • Preporučuje se tabletu progutati cijelu s vodom.
English: Allow the parts to dry completely prior to reassembly.
Croatian: Pustite da se dijelovi u potpunosti osuše prije nego što ih ponovno sastavite.
English: UNIQUE IDENTIFIED - 2D BARCODE
Croatian: 17. JEDINSTVENI IDENTIFIKATOR - 2D BARKOD
English: What Stocrin is and what it is used for
Croatian: Što je Stocrin i za što se koristi
English: The incidence of erythema multiforme or Stevens-Johnson syndrome was approximately 0.1 %.
Croatian: Incidencija multiformnog eritema ili Stevens-Johnsonovog sindroma bila je približno 0,1%.
English: In controlled trials the frequency of specific serious psychiatric events were:
Croatian: U kontroliranim ispitivanjima učestalost specifičnih ozbiljnih psihijatrijskih događaja bila je sljedeća:
English: Keep the medicine container with you so that you can easily describe what you have taken.
Croatian: Ponesite sa sobom bocu lijeka da lakše možete opisati što ste uzeli.
English: rare photoallergic dermatitis
Croatian: rijetko fotoalergijski dermatitis
English: 90 % confidence intervals unless otherwise noted.
Croatian: 90% interval pouzdanosti, osim ako nije drugačije navedeno.
English: Your doctor has prescribed Stocrin for you because you have HIV infection.
Croatian: Liječnik Vam je propisao Stocrin jer ste zaraženi HIV-om.
English: If available, 90 % or 95 % confidence intervals are shown in parentheses.
Croatian: Ako su dostupni, podaci o intervalima pouzdanosti od 90% ili 95% navedeni su u zagradama.
English: Other medicines and Stocrin
Croatian: Drugi lijekovi i Stocrin
English: No child had severe symptoms or had to discontinue because of nervous system symptoms.
Croatian: Nijedno dijete nije imalo teške simptome niti je moralo prekinuti liječenje zbog simptoma živčanog sustava.
English: ATC code: J05A G03
Croatian: ATK oznaka: J05A G03
English: , neurosis
Croatian: , neuroza
English: 13 to < 15 15 to < 20 20 to < 25 25 to < 32.5 32.5 to < 40
Croatian: 13 do < 15 15 do < 20 20 do < 25 25 do < 32,5 32,5 do < 40
English: If you are pregnant, you should take Stocrin only if you and your doctor decide it is clearly needed.
Croatian: Ako ste trudni, Stocrin smijete uzimati samo ako ste zajedno s liječnikom odlučili da je to neophodno.
English: 3 - < 5 years
Croatian: 3 - < 5 godina